Data as of May 20
| +0.02 / +1.13%|
The 4 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 4.50. The median estimate represents a +291.06% increase from the last price of 1.79.
The current consensus among 4 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.